<unk>  is an antineoplastic and antibiotic that is FDA approved for the treatment of women with axillary lymph node involvement following resection of primary breast cancer, leukemias, lymphomas and metastasis neoplasms.. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include alopecia, nausea and vomiting.
Doxorubicin hydrochloride
Zorubicin
Paclitaxel
Vincristine sulfate
Epirubicin hydrochloride
Idarubicin hydrochloride
Taxane
Irinotecan hydrochloride 